Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/SAKAR stock hub

NSE/SAKAR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/SAKARis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.1B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/SAKAR

In the news

Latest news · NSE/SAKAR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E48

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC8.4

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/SAKAR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

INR

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	342
Employees Change	17%
Employees Change Percent	5.23
Enterprise value	INR 13B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE732S01012
Last refreshed	2026-05-10
Market cap	INR 12.1B
Price	INR 544
Price currency	INR
Rev Per Employee	6,766,166.67x
Sector	Healthcare
Sic	2834
Symbol	nse/SAKAR
Website	https://www.sakarhealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.08%
EV Earnings	51.49x
EV/EBIT	35.89x
EV/EBITDA	22.52x
EV/Sales	5.61x
P/B ratio	4x
P/E ratio	47.99x
P/S ratio	5.25x
PE Ratio10 Y	28.13x
PE Ratio3 Y	43.98x
PE Ratio5 Y	35.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.64%
EBITDA Margin	24.92%
Gross margin	52.59%
Gross Profit	INR 1.2B
Gross Profit Growth	55.65%
Gross Profit Growth Q	67.46%
Gross Profit Growth3 Y	27.72%
Gross Profit Growth5 Y	24.97%
Net Income	INR 252.2M
Net Income Growth	69.71%
Net Income Growth Q	126.12%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	12.35%
Net Income Growth5 Y	16.39%
Pretax Margin	12.07%
Profit Margin	10.9%
Profit Per Employee	INR 737,465
Profitable Years	16
Roa5y	4.9
Roe5y	9.12
ROIC	8.42
Roic5y	7.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	101.5%
Cagr3y	35.86%
Cagr5y	29.89%
EPS Growth	65.96
EPS Growth Q	120.7
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth3 Y	5.23
EPS Growth5 Y	7.62
Revenue Growth	35.15x
Revenue Growth Q	62.02x
Revenue Growth Quarters	13x
Revenue Growth Years	13x
Revenue Growth3 Y	21.13x
Revenue Growth5 Y	20.45x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 2.2M
Debt	INR 850.8M
Debt EBITDA	INR 1.48
Debt Equity	INR 0.28
Equity	INR 3B
Interest Coverage	4.02
Net Cash	INR -848.7M
Net Cash By Market Cap	INR -6.99
Net Debt EBITDA	INR 1.47
Net Debt Equity	INR 0.28
Tangible Book Value	INR 3B
Tangible Book Value Per Share	INR 133
WACC	6.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	101.41%
200-day SMA	422.2
3Y total return	150.81%
50-day SMA	557.9
50-day SMA vs 200-day SMA	50over200
5Y total return	269.69%
All Time High	662
All Time High Change	-17.82%
All Time High Date	2026-04-29
All Time Low	44
All Time Low Change	1,136.36%
All Time Low Date	2019-09-13
ATR	37.55
Beta	0.29
Beta1y	-0.03
Beta2y	0.02
Ch YTD	32.94
High	568.9
High52	662
High52 Date	2026-04-29
High52ch	-17.82%
Low	537.1
Low52	264.3
Low52 Date	2025-05-09
Low52ch	105.87%
Ma50ch	-2.48%
Price vs 200-day SMA	28.84%
RSI	40.89
RSI Monthly	67.26
RSI Weekly	60.7
Sharpe ratio	1.66x
Sortino ratio	3.09
Total Return	-2.26%
Tr YTD	32.94
Tr1m	2.87%
Tr1w	-16.63%
Tr3m	24.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 361.8M
Operating Income Growth	40.7
Operating Income Growth Q	87.15
Operating Income Growth3 Y	20.39
Operating Income Growth5 Y	19.04
Operating margin	15.64

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,928,900%
Shares Insiders	52.41%
Shares Out	22,249,900
Shares Qo Q	-0.15%
Shares Yo Y	2.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	112,261.4x
Bv Per Share	136.3
Ch1m	2.87
Ch1w	-16.63
Ch1y	101.4
Ch3m	24.4
Ch3y	150.8
Ch5y	269.7
Ch6m	44.95
Change	-1.98%
Change From Open	-1.09
Close	555
Days Gap	-0.9
Depreciation Amortization	214,857,000
Dollar Volume	51,079,424
Earnings Date	2026-05-12
EBIT	INR 361.8M
EBITDA	INR 576.7M
EPS	INR 11.37
F Score	2
Fiscal Year End	March
Founded	2,004
Graham Number	186.70147
Graham Upside	-65.68
Income Tax	INR 27.1M
Is Primary Listing	1
Last Earnings Date	2026-02-05
Last Report Date	2025-12-31
Lynch Fair Value	INR 186
Lynch Upside	-65.75
Ma150	449.2
Ma150ch	21.11%
Ma20	608.6
Ma20ch	-10.62%
Next Earnings Date	2026-05-12
Open	550
Position In Range	21.73
Price Date	2026-05-08
Price EBITDA	INR 21.05
Ptbv Ratio	4.11
Relative Volume	0.85x
Revenue	2,314,029,000x
Tax By Revenue	1.17x
Tax Rate	9.7%
Tr6m	44.95%
Volume	93,896

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/SAKAR pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/SAKAR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/SAKAR?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+52.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.3%

Negative means the company is buying back shares.

Technical

NSE/SAKAR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.9

Neutral momentum band

Price vs 200-day MA

+28.8%

50/200-day relationship not available

Beta (5Y)

0.29

Less volatile than the market

Sharpe ratio

1.66

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/SAKAR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/SAKAR stock rating?

nse/SAKAR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/SAKAR analysis?

The full report lives at /stocks/nse/SAKAR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/SAKAR?

The latest report frames nse/SAKAR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/SAKAR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.